1800-272-662
Shopping Cart 0
countryflagAU
Login

Trivarx Ltd

Healthcare AU TRI

0.02AUD
-0.001(4.76%)

Last update at 2026-03-13T05:10:00Z

Day Range

0.020.02
LowHigh

52 Week Range

0.0070.04
LowHigh

Fundamentals

  • Previous Close 0.02
  • Market Cap24.23M
  • Volume1945700
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-2.15302M
  • Revenue TTM-0.09536M
  • Revenue Per Share TTM-
  • Gross Profit TTM -0.08767M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax -1.97430M -1.23709M -3.11970M -12.71581M -1.48660M
Minority interest - - - - -
Net income -0.94323M -1.23709M -3.11970M -12.72450M -2.65573M
Selling general administrative 0.97M 1.07M 0.75M 1.41M 1.19M
Selling and marketing expenses - 0.05M 0.08M 0.02M 0.00709M
Gross profit -0.05247M 0.89M 0.02M 0.04M -0.06904M
Reconciled depreciation - 0.09M 0.54M 0.45M 0.20M
Ebit -1.94068M -1.22365M -1.78834M -2.67050M -1.48031M
Ebitda -1.88821M -1.13051M -1.24731M -2.22165M -1.28179M
Depreciation and amortization 0.05M 0.09M 0.54M 0.45M 0.20M
Non operating income net other - - - - -
Operating income -2.03858M -1.42117M -1.78834M -2.67050M -1.48031M
Other operating expenses 2.04M 2.31M 2.75M 3.68M 2.74M
Interest expense 0.03M 0.01M 0.01M 0.00869M 0.00629M
Tax provision - 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.00512M 0.00416M 0.01M 0.00869M 0.02M
Net interest income - -0.00897M -0.01326M -0.00869M -0.01495M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -1.03107M - 0.95M 0.00869M 1.17M
Total revenue 1.13M 0.89M 0.02M 0.04M 0.10M
Total operating expenses 1.99M 2.31M 2.75M 3.68M 2.57M
Cost of revenue 0.05M 0.00000M 0.00016M 0.00107M 0.17M
Total other income expense net 0.06M -1.23709M -0.37642M -10.04531M -0.00629M
Discontinued operations - - - - -
Net income from continuing ops - -1.43462M -3.11970M -12.71581M -1.48660M
Net income applicable to common shares -0.94323M -1.43462M -3.11970M -12.71581M -1.48660M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 13.48M 11.07M 8.06M 8.49M 17.38M
Intangible assets 12.01M 10.13M 7.63M 7.21M 14.69M
Earning assets - - - - -
Other current assets 0.05M 0.07M 0.09M 0.17M 0.32M
Total liab 0.83M 1.17M 1.76M 1.38M 0.96M
Total stockholder equity 12.65M 9.89M 6.30M 7.11M 16.42M
Deferred long term liab - - 2.47M 2.01M 4.38M
Other current liab - 0.16M 0.13M 0.31M 0.04M
Common stock 109.96M - 101.80M 99.45M 96.07M
Capital stock - 106.58M 101.80M 99.45M 96.07M
Retained earnings -97.30740M -102.96889M -101.70504M -98.58534M -85.86953M
Other liab - - - - -
Good will - - - - -
Other assets 0.00776M - 0.02M 2.02M 4.39M
Cash 1.25M 0.85M 0.21M 1.03M 2.31M
Cash and equivalents - - - - -
Total current liabilities 0.70M 1.17M 1.76M 1.38M 0.96M
Current deferred revenue - - 0.14M - 0.13M
Net debt - - -0.11041M -0.96615M -2.28674M
Short term debt 0.00000M - 0.10M 0.07M 0.02M
Short long term debt - - - - -
Short long term debt total - - 0.10M 0.07M 0.02M
Other stockholder equity - - 6.20M 6.24M 6.22M
Property plant equipment 0.16M - 0.11M 0.07M 0.02M
Total current assets 1.30M 0.92M 0.30M 1.20M 2.66M
Long term investments - - - - -
Net tangible assets - - 1.18M 1.90M 6.11M
Short term investments - - - - -
Net receivables - - - - 0.03M
Long term debt - - - - -
Inventory - - - - -
Accounts payable - 0.94M 1.38M 1.00M 0.76M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - 6.20M 6.24M 6.22M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 0.00767M 0.02M 0.01M 0.00676M
Deferred long term asset charges - - - - -
Non current assets total - 10.15M 7.75M 7.29M 14.72M
Capital lease obligations - 0.02M 0.10M 0.07M 0.02M
Long term debt total 0.13M - 0.00000M 0.00000M 0.00000M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments - -2.50043M -2.25867M -3.10955M -1.83196M
Change to liabilities - - 0.26M 0.39M -0.44343M
Total cashflows from investing activities -2.09133M -2.84861M -2.25867M -3.10955M -1.83196M
Net borrowings - -0.00550M -0.04000M -0.04495M -0.05209M
Total cash from financing activities 2.68M 4.32M 2.47M 3.33M 4.92M
Change to operating activities - - -0.02501M 0.26M -0.22252M
Net income -0.94323M -1.43462M -3.11970M -12.72450M -1.49289M
Change in cash 0.40M 0.63M -0.81845M -1.27899M 1.50M
Begin period cash flow 0.85M 0.21M 1.03M 2.31M 0.81M
End period cash flow 1.25M 0.85M 0.21M 1.03M 2.31M
Total cash from operating activities -0.18974M -1.47543M -0.93208M -12.27564M -1.70089M
Issuance of capital stock - 4.70M 2.51M 3.38M 4.97M
Depreciation 0.05M - 0.10M 0.45M 0.20M
Other cashflows from investing activities - - 0.00000M 0.00000M 0.00133M
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables - - - 0.02M 0.00035M
Sale purchase of stock 2.73M 4.70M 2.51M 3.38M 4.97M
Other cashflows from financing activities -0.05511M -0.12366M -0.04000M -0.04495M -0.05209M
Change to netincome - - 1.36M 10.61M 0.25M
Capital expenditures 2.09M 2.85M 2.26M 3.11M 1.83M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.47M 0.89M 0.94M 0.97M 1.12M
Stock based compensation - - - - -
Other non cash items 0.23M - - 12.28M 1.29M
Free cash flow -0.18974M -3.69692M -3.19075M -15.38519M -3.53417M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
TRI
Trivarx Ltd		 -0.001 4.76% 0.02 - 5.58 23.50 1.08 79.57 -0.3188
PME
Pro Medicus Ltd		 -0.55 0.41% 133.00 59.62 73.53 58.00 36.74 58.50 75.61
AYA
ARTRYA Ltd		 -0.17 5.04% 3.20 - - 17488.26 5.98 5516.69 0.33
EIQ
Echoiq Ltd		 0.02 2.94% 0.70 - - 5046.68 25.81 4779.15 -8.2701
CGS
Cogstate Ltd		 -0.02 0.92% 2.15 23.89 19.96 6.58 5.14 4.32 13.45

Reports Covered

Stock Research & News

View All

Profile

TrivarX Limited, a health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as Medibio Limited and changed its name to TrivarX Limited in October 2023. TrivarX Limited was incorporated in 1987 and is based in Mount Lawley, Australia.

Trivarx Ltd

647 Beaufort Street, Mount Lawley, WA, Australia, 6050

Key Executives

Name Title Year Born
Dr. Thomas R. Young M.D. Chief Exec. Officer NA
Ms. Renee Stanton-Horne Operations & Account Mang. NA
Ms. Stephanie Ottens Investor Relations Director NA
Mr. Josh Purdy PR Director NA
Dr. Michael Player Head of Research NA
Dr. Matthew Flax Head of Algorithm Devel. Team NA
Mr. Archie Defillo M.D. Chief Medical Officer NA
Ms. Jennifer Solitario Sr. VP of Corp. Health NA
Mr. Massimiliano Grassi Head of Artificial Intelligence NA
Mr. Mathew Watkins C.A. Company Sec. NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.